Osteopathy Treatment for Cancer Pain Related to the Confinement to Bed

Osteopathy Treatment for Cancer Pain Related to the Confinement to Bed Pilot Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03440957

Acronym

OSTEO

Enrollment

Registered

2018-02-22

Start date

2018-02-21

Completion date

2020-02-02

Last updated

2022-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Patient Confined in the Bed

Keywords

advanced cancer, osteopathy, pain, bedridden

Brief summary

Staying confined in the bed is frequent at the end of life. The cancer patients can also experiment this situation, and consequences are painful, with pain increasing with the time. This pain are related to the joints stiffing , muscles mass decreasing, and tendons retractions . The non pharmacological approach associated with the conventional treatments can be interesting to assess in this frails patients.

Interventions

OTHEROsteopathic treatment

The patients meeting the inclusions criteria will be informed of the study and an osteopathic treatment holistic ,involving all the body will be applied, three time with 2 days between the treatments .Each meeting with the practitioner will last around 40 minutes. The pain and symptoms assessment will be done before and after the treatment .

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Man or woman * Aged 18 years or older * Having signed informed consent to participate in the study * Patient affiliated to a social security scheme * Patient with pain affecting the musculoskeletal system following prolonged bed rest * Capable to understand French * Capable of completing self-assessment scales

Exclusion criteria

* Patients with bone metastases at risk for the use of osteopathy * Patients under legal protection measures * Patients with cognitive impairment preventing self-evaluation * Patient who is considered too fragile or with a clinical condition too unstable by the doctor refer to be included in the study * Patients in the pre-agonic or agonic phase

Design outcomes

Primary

Measure	Time frame
Decreased pain intensity of 2 points measured by Analog Visual Scale (AVS) before and after the session	15 days

Secondary

Measure	Time frame
Decrease in analgesic consumption for pain related to immobilization	15 days
Decreased 2 points of intensity of other symptoms associated before and after session measured with Edmonton Symptom Assessment System (ESAS).	15 days

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026